Compare Berkeley Advanced Biomaterials vs BioSyntech Canada
Customers evaluate the quality of Berkeley Advanced Biomaterials's products using the following success metrics.
Overview
Berkeley Advanced Biomaterials is based in United States
Berkeley Advanced Biomaterials Inc. (BAB) specializes in developing and manufacturing hydroxyapatite (HAP), tricalcium phosphate (TCP), and other calcium-based products. The company's activities are focussed on synthetic bone graft substitutes, sustained-release drug delivery devices, and applications of HAP for protein purification. The company's catalog offers a large variety of products with tailored morphologies and microstructures to match their needs for orthopedic surgery, bone tissue engineering, and life science research. Cem-Ostetic and Bi-Ostetic bone void fillers are approved for sale in the USA and the European Community.
BioSyntech Canada is 30 yrs old and is based in Canada.
BioSyntech specializes in the discovery, development and manufacturing of biotherapeutic thermogels for regenerative medicine and therapeutic delivery. Its platform technology is a family of hydrogels that can be injected or applied to specific sites and which offer beneficial properties for the local repair of damaged tissue such as cartilage, bone and chronic wounds.
Demo Video
Leadership
Jeanne Bertonis (President)
Funding
Investors
Pappas Ventures, ProQuest Investments
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Berkeley Advanced Biomaterials has not claimed their profile.
Work for Berkeley Advanced Biomaterials? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Berkeley Advanced Biomaterials?
Claim your profile now.
Information not available because BioSyntech Canada has not claimed their profile.
Work for BioSyntech Canada? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for BioSyntech Canada?
Claim your profile now.